1. Edgewise Therapeutics, BioFrontiers Institute University of Colorado Boulder Colorado USA
2. The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute Newcastle University and Newcastle Hospitals NHS Foundation Trust Newcastle upon Tyne UK
3. Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences Binghamton University – State University of New York Binghamton New York USA